Top Health Tech Companies in Chicago, IL (686)
EliseAI builds vertical AI agents for housing and healthcare — sectors that together make up nearly 40% of household spending. These agents automate high-volume workflows like leasing, maintenance, renewals, and patient intake, helping organizations cut costs, improve efficiency, and deliver better experiences. How does it work? EliseAI integrates directly into operational workflows: Housing: Manages leasing, maintenance, renewals, billing, and resident communication. Healthcare: Handles intake,...
EliseAI's Top Stability & Growth Strengths
Strong Revenue Growth: Reported ARR surpassed $200 million in June 2026 with five consecutive years of 100% year-over-year growth, indicating rapid scaling. Adoption breadth, including claims of powering one in six U.S. apartments, reinforces the commercial momentum behind that trajectory.
Investor Backing & Capital Strength: A $350 million round in September 2026 at a $4 billion valuation, with major existing investors participating alongside Ontario Teachers’ Pension Plan, underscores substantial access to capital. This financing signals strong confidence to fund continued product development and go-to-market expansion.
Market Expansion: Reach reportedly grew from about one in twelve U.S. apartments in 2024 to one in six in 2026, alongside plans for a second engineering hub in San Francisco. The company is also expanding from leasing into broader property-management workflows and healthcare administration.
Prolaio is a clinical intelligence company dedicated to unlocking continuous, predictive and shareable heart data to liberate patients from hospital-based reactive care and accelerate every new therapy. The company was created by cardiologists, cardiovascular practitioners, and data scientists specifically to address the world’s number one cause of death — cardiovascular disease. By combining scientific rigor with cutting‑edge technology, Prolaio aims...
Prolaio's Top Stability & Growth Strengths
Strong Hiring & Retention: Workforce expansion is evident, with Prolaio reporting 32 new hires in 2025 and continuing to recruit across technical and customer-facing roles. These signals point to organizational scaling backed by ongoing capacity investment.
Product Line Growth: Product capabilities advanced with the launch of the OCORO study and an FDA 510(k) clearance for the eVO2peak module in 2025. These developments broaden the digital cardiovascular biomarker portfolio and can support wider clinical use.
Strategic Partnerships: The 2025 acquisition by Kardigan ties Prolaio’s cardiovascular data platform directly to active drug-development programs. This connection creates avenues for expanded clinical deployments and operational scale.
We are a purpose driven healthcare technology company passionate about innovation and using technology to help people by solving real world problems. The ALIS team designs, builds, delivers, and supports our flagship product ALIS (pronounced “Alice” and stands for Assisted Living Integrated Solution).
ALIS's Top Stability & Growth Strengths
Strong Revenue Growth: Management reported strong revenue growth in the prior year alongside expanded market share. A larger Chicago office and plans to scale headcount were presented as aligned with this momentum.
Product Line Growth: The platform has expanded from EHR/eMAR into CRM, billing, business intelligence, family engagement, and AI, and it added dementia and behavioral‑care tools through the Ella and elbi acquisition in 2026. Continued integrations and an AI assistant indicate active product development.
Market Expansion: The company cites use across more than 3,000 communities and 200,000 residents in 40+ states. New and expanded integrations throughout 2026 support broader reach and stickiness with operators.
Our mission is to improve health outcomes through behavior change at the point of care and beyond. Every day, people make choices that shape their health, and at PatientPoint, we strive to support those decisions with the right information delivered at the right time. We're proud to power the largest network of digital devices in doctor's offices across the country —...
PatientPoint's Top Stability & Growth Strengths
Strong Revenue Growth: Company disclosures point to multi‑year top‑line expansion, with independent credit commentary anticipating continued gains. The scale of the installed healthcare network reinforces commercial traction over time.
Market Expansion: Recent launches of a Consumer Health Network and programmatic advertising capabilities extend reach beyond traditional pharmaceutical clients and open new buying channels. These moves indicate active growth into adjacent advertiser categories within healthcare settings.
Investor Backing & Capital Strength: A definitive agreement to be acquired by a global private‑equity firm underscores institutional confidence and adds resources to accelerate network growth and product innovation. The transaction highlights access to capital to support scaling.
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Strong Hiring & Retention: Headcount and hiring momentum are evident, with third-party estimates showing growth from roughly the mid‑teens of thousands in 2024 to 20,000+ by 2025–2026 and plans to hire thousands, alongside new capacity such as the Hyderabad operations center. This suggests the company is scaling delivery and talent depth across geographies.
Innovation-Driven Growth: The firm has expanded into AI and digital offerings, including its ZAIDYN platform, acquisitions like Digital Additive and Torrent Consulting, and launches such as Myelo developed with the International Myeloma Foundation. These moves indicate investment beyond traditional consulting into scalable, tech‑enabled services.
Market Expansion: A dedicated mid‑cap pharmaceutical vertical and the opening of an operations center in Hyderabad point to deliberate expansion in target segments and delivery footprint. These steps signal efforts to broaden served markets and strengthen execution capacity.
We bring together one of the world’s largest libraries of multimodal clinical and molecular data with a robust suite of AI tools to help physicians personalize care in real time, connect patients with therapies and clinical trials, and enable partners to accelerate discovery and development of new treatments. With ~8 million de-identified research records and 350+ petabytes of data, Tempus partners...
Tempus AI's Top Stability & Growth Strengths
Strong Revenue Growth: Recent financial results highlight sustained top-line expansion with rising quarterly revenue and management increasing full‑year guidance, indicating momentum across 2025 and into 2026.
Diversified Revenue Streams: Growth is coming from both diagnostics and data licensing/AI applications, with testing volumes and data contracts expanding rather than reliance on a single line of business.
Customer Loyalty & Retention: Reported net revenue retention above 100% and sizable remaining contract value suggest existing pharmaceutical customers are deepening engagements.
.png){kind=logo}
Here at Strata, we provide financial planning software, data, and insights to drive decisions and performance for organizations spanning the healthcare, higher education, and financial services industries.
Strata Decision Technology's Top Stability & Growth Strengths
Market Expansion: Expansion into higher education and financial institutions, coupled with the integration of Syntellis and the acquisition of c. myers, broadened capabilities and reach. This indicates widening commercial avenues beyond the core healthcare base.
Innovation-Driven Growth: New AI-powered offerings—Predictive Analytics and Financial Decision Intelligence—were launched within the StrataJazz platform. These additions signal sustained product investment to deepen value and use cases.
Diversified Customer Base: Strata reports serving more than 2,300 organizations across healthcare, higher education, and financial institutions. This spread reduces reliance on a single sector and provides multiple paths for growth.
Home Care Delivered (HCD) is a medical-supply provider that helps patients obtain insurance-covered products tailored to their health needs, working with physicians and navigating coverage requirements. It specializes in urology, wound care, incontinence, ostomy, diabetes/continuous glucose monitoring, and nutrition products. HCD coordinates the process from product selection and insurance support through discreet, scheduled home delivery, and provides educational resources and...
CareVia is dedicated to providing a more effective and affordable solution for patient monitoring with a platform rooted in communications technology that leverages simplicity and flexibility to solve some of healthcare’s biggest challenges. As both a device and network agnostic solution, CareVia is able to bridge the information gap that exists in the space between consumer medical devices, healthcare professionals...
At Ryan Companies, we believe the value of the buildings we design, develop, finance, manage and construct is about more than dollars and cents – it’s also about the value they bring to the people who use them and the communities that surround them.
Ryan Companies's Top Stability & Growth Strengths
Strong Revenue Growth: Midwest revenue increased from $153.9 million in 2023 to $198 million in 2024, signaling tangible momentum in a core region.
Market Expansion: Southeast delivery reached 2.4 million square feet with $353 million in new development, alongside a national footprint with offices across the United States.
Strong Brand Reputation: Recognition as 2026 North American Developer of the Year highlights industry standing, and technology accolades reinforce credibility in modern delivery methods.
U.S. Renal Care is the largest privately held and fastest-growing dialysis provider in the nation. We partner with nephrologists to care for more than 36,000 people living with kidney disease across 32 states in the U.S. Since 2000, U.S. Renal Care has been a leader in clinical quality, innovation, and operational excellence – delivering the best experience and outcomes for...
U.S. Renal Care's Top Stability & Growth Strengths
Market Expansion: The company reports growing from about 25,000 patients in 335 facilities (2019) to caring for more than 36,000 people across 500+ centers in 32–33 states, indicating a larger national footprint. Continued openings and 200+ home programs suggest expansion across both in‑center and home modalities.
Investor Backing & Capital Strength: USRC raised $328 million in 2023 and refinanced debt to lower interest costs and extend maturities, with proceeds positioned to fund expansion, home therapies, and value‑based care. Capital access has been used to scale home programs and value‑based initiatives.
Strategic Partnerships: Physician joint ventures underpin local market penetration and clinical alignment across the network. Multi‑year collaborations and the Kidneylink value‑based platform broaden capabilities in home dialysis and integrated kidney care.
Inizio Evoke is a global health marketing, communications, and transformation platform unlocking growth through data-driven insights and human centricity. We are purpose-built to make Health more human™. With core expertise and specialty brands in Marketing, Comms, Transformation, Access, and Media, we serve as a premier partner for the world's most ambitious healthcare organizations. Inizio Evoke is an Inizio company. Inizio...
Inizio Evoke's Top Stability & Growth Strengths
Strong Market Position & Advantage: Repeated Top 10 placement in MM+M’s Agency 100 (including #9 in 2025 based on 2024 revenue) and finalist recognition for Healthcare Network of the Year signal durable top-tier standing. Industry lists and client accolades indicate competitiveness even if not the largest by revenue.
Innovation-Driven Growth: Investments in AI-enabled solutions (e.g., Predictev™ and Cognitev™) and creation of an EVP role for AI Transformation demonstrate a clear push to scale data- and technology-led offerings. The 2024 unification under one platform strengthens omnichannel and audience intelligence capabilities.
Future-Ready Strategy: A unified model spanning marketing, communications, transformation, access, and media within the broader Inizio ecosystem positions delivery across the commercialization lifecycle. Consistent rankings and strategic hires point to preparedness for re-acceleration as integration benefits compound.
Pinnacle Live is an event experience company that is fundamentally changing the dynamics between premiere hotels, customers and partners to unleash the power of live events. We offer a new and modern approach that will create unforgettable human connections among our customers, our industry partners, our communities, and society at large.
Pinnacle Live's Top Stability & Growth Strengths
Market Expansion: Feedback suggests the company is expanding its national hotel footprint with nearly 200 preferred hotel/resort partnerships and recent additions in South Florida. Marquee wins like Fontainebleau Miami Beach and properties such as JW Marriott Miami Turnberry, Omni Fort Lauderdale, and Pier Sixty‑Six indicate traction in key luxury markets.
Strategic Partnerships: Feedback suggests multi‑year and exclusive agreements (e.g., portfolio‑wide Omni Hotels & Resorts and exclusive at Fontainebleau Miami Beach) are strengthening access to high‑profile venues. The company cites a growing roster of preferred in‑house relationships across North America that reinforce its venue‑embedded model.
Innovation-Driven Growth: Feedback suggests acquisitions and new offerings—such as the Falcon Events acquisition, the launch of EDGE, and an Event Production division—are broadening hybrid/virtual, creative, and high‑complexity production capabilities. Added infrastructure like a Seattle enablement facility supports scaling and execution.
Regroup is a telepsychiatry-as-a-service company. We work to eradicate mental health shortage areas across the nation by providing platform, process and people to deliver excellent quality telehealth solutions for health entities.
Daxko powers health and wellness throughout the world. Every day, our team members bring their passion and expertise to help health and wellness facilities operate smoothly and engage their members. Whether it’s supporting a fitness club, a community center, or a local boutique studio, Daxko is there, powering 40% of fitness and wellness facilities nationwide. We’re more than just a tech...
Daxko's Top Stability & Growth Strengths
Strong Market Position & Advantage: Feedback suggests the company holds a clear leadership position within its niche segments, particularly across YMCAs, JCCs, enterprise clubs, and community wellness organizations. Scale across tens of thousands of facilities and a comprehensive, all-in-one ecosystem reinforce this advantage.
Market Expansion: Feedback suggests continued expansion via international growth, notably through acquisitions like FitnessForce in India and broader geographic reach across dozens of countries. Partnerships and integrations further extend presence into adjacent markets and use cases.
Strategic Partnerships: Feedback suggests an expanding ecosystem of integrations (e.g., payroll/HR and childcare compliance) that deepens utility for core customer segments. These collaborations enhance platform stickiness and broaden solution coverage.
OpenMarkets simplifies the equipment buying and selling process through connected workflows, direct supplier access, and smarter planning.
Healthihelp operates websites that are designed to create a conversation around healthcare transparency, healthcare costs and user experiences. We believe that healthcare should be transparent, consumers should know the costs of healthcare and have a place to talk about it.
At Humana, our cultural foundation is aligned to helping members achieve their best health by delivering personalized, simplified, whole-person healthcare experiences. Recognizing healthcare needs continue to evolve for each person, for each family and for each community, Humana continuously creates innovative solutions and resources that help people live their healthiest lives on their terms –when and where they need it....
Humana's Top Stability & Growth Strengths
Strong Market Position & Advantage: Humana is a top-tier player in Medicare Advantage with substantial local dominance across many counties and an integrated senior-care platform via CenterWell. Its scale in MA and senior-focused delivery underpins leadership in its core segment.
Strong Revenue Growth: Revenue has been rising, with year-over-year increases and higher 2025 guidance. Momentum is supported by CenterWell contributions and higher prescription volumes.
Future-Ready Strategy: Management is pruning low-margin geographies, repricing benefits, and concentrating on government programs and CenterWell to strengthen long-term earnings quality. Product and footprint adjustments for 2026, alongside early signs of star-rating stabilization, point to a rebuild path.
NorthStar Anesthesia is one of the largest anesthesia management companies in the United States. Founded by an Anesthesiologist and a CRNA more than 10 years ago, we have built a foundation of anesthesia expertise unparalleled in the market. NorthStar delivers a transformational anesthesia model, emphasizing a culture of mutual respect and accountability. Our clinical leadership works in partnership with our...
La Rabida Children’s Hospital is a pediatric acute care hospital, specializing in the treatment of chronic illnesses and developmental disabilities. La Rabida provides family-centered interdisciplinary care to 7,500 children with special healthcare needs each year at its lakeside location in Chicago. See our open jobs at https://larabidajobs.com/#job-feed
